Free Trial

Capital Fund Management S.A. Makes New Investment in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Sabra Health Care REIT logo with Finance background

Capital Fund Management S.A. purchased a new stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 144,354 shares of the real estate investment trust's stock, valued at approximately $2,500,000. Capital Fund Management S.A. owned approximately 0.06% of Sabra Health Care REIT at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Principal Financial Group Inc. lifted its position in Sabra Health Care REIT by 2.5% in the 4th quarter. Principal Financial Group Inc. now owns 22,109,683 shares of the real estate investment trust's stock valued at $382,940,000 after acquiring an additional 536,247 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Sabra Health Care REIT by 4.3% during the fourth quarter. JPMorgan Chase & Co. now owns 10,312,991 shares of the real estate investment trust's stock valued at $178,621,000 after buying an additional 426,074 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Sabra Health Care REIT by 1.4% during the fourth quarter. Geode Capital Management LLC now owns 6,381,525 shares of the real estate investment trust's stock valued at $110,550,000 after buying an additional 86,727 shares during the last quarter. Bank of New York Mellon Corp raised its position in Sabra Health Care REIT by 13.0% in the 4th quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust's stock valued at $69,967,000 after buying an additional 463,601 shares during the last quarter. Finally, Wellington Management Group LLP lifted its stake in Sabra Health Care REIT by 33.7% during the 4th quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock valued at $55,511,000 after acquiring an additional 808,207 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on SBRA. JMP Securities upgraded shares of Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 target price for the company in a report on Tuesday, January 7th. Truist Financial boosted their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a research note on Tuesday, March 18th. Finally, Citizens Jmp raised Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Sabra Health Care REIT presently has an average rating of "Moderate Buy" and an average price target of $19.33.

Get Our Latest Stock Analysis on SBRA

Sabra Health Care REIT Trading Down 0.2 %

Shares of NASDAQ SBRA traded down $0.03 during mid-day trading on Friday, hitting $18.14. The stock had a trading volume of 2,252,110 shares, compared to its average volume of 2,136,412. The firm has a market cap of $4.32 billion, a P/E ratio of 34.23, a price-to-earnings-growth ratio of 1.97 and a beta of 0.93. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. The business has a 50 day moving average price of $17.02 and a two-hundred day moving average price of $17.53. Sabra Health Care REIT, Inc. has a 1 year low of $13.49 and a 1 year high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, hitting analysts' consensus estimates of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The company had revenue of $182.35 million during the quarter, compared to analyst estimates of $178.01 million. On average, equities analysts anticipate that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.62%. The ex-dividend date was Friday, February 14th. Sabra Health Care REIT's payout ratio is currently 226.42%.

About Sabra Health Care REIT

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Featured Stories

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Health Care REIT Right Now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines